This literature review updates the reader on the new studies regarding steroid therapy over
the last year in stable COPD and in exacerbations. In stable COPD, we critique the 2011 …

Introduction Discordance between real-world prescribing patterns and global treatment
guidelines for the treatment of chronic obstructive pulmonary disease (COPD) with inhaled …

Blood eosinophils measurement, as proxy for tissue eosinophils, has become an important
biomarker for exacerbation risk and response to inhaled corticosteroids (ICS) in Chronic …

Background There is controversy regarding the use of blood eosinophil levels as a
biomarker of exacerbation risk and responsiveness of patients to inhaled corticosteroids …

In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

Background and aim: Chronic obstructive pulmonary disease (COPD) is a major cause of
morbidity and mortality, and through under-diagnosis, is often inappropriately treated. This …

Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with
significant morbidity and mortality [ 1]. Current guidelines advocate the use of systemic …

In recent years, research has revealed more about the factors underlying the pathogenesis
of chronic obstructive pulmonary disease (COPD). In particular, inflammation in the lungs …

Chronic obstructive pulmonary disease (COPD) guidelines and strategies suggest
escalating treatment, mainly depending on the severity of airflow obstruction. However …

Introduction: Patients can have features of both chronic obstructive pulmonary disease
(COPD) and asthma. However, there is still no consensus how to precisely define this …